Blog / Archives
FED Comments Focus On “Bubble” Stocks In Social Media and Biotech…. Update-1
Update 8PM EDT NASDAQ Holds Losses to 0.54%-Futures Stable Biotech Damage Across the Sector-Rayno Life Science Portfolio Notes Large Caps off about 2% (FBT), but Gilead (GILD) down only 0.95% and...
Tepid Rally Favors Large Caps: ABBV, GILD, RHHBY
Healthcare Stocks trail other sectors up 0.34%, Energy up 0.8%, Financials up 0.73% and Technology up 0.77% But biotech ETFs are in the Green Biotechnology stocks were mixed today with the...
Risk Off: Take Profits in Biotech Stocks… Update -1
Re-iterate call from Tuesday....futures down 0.8%-Russell down 2%, gold up, Japan and Europe down.. Bad Tape Yesterday (7/7) Calls For Raising Cash NASDAQ at 4451 up 6.58% YTD Major ETFs and...
Rayno Life Sciences: First Half Stock Performance Part 2-ILMN, SQNM
Rayno Diagnostics and Tools-Sequencing Rules Diagnostics and Tools stocks tracked biotech stocks during the huge moves in January/February and sold off until the April bottom. However stocks that...
Rayno Life Sciences: First Half Stock Performance Part I-ACHN, AMRI, VRTX
Biopharmaceutical Stocks Come Roaring Back After Q1 Correction Most Stocks Bottomed in April -We are Currently in Rally Mode The biotech sector is up 18% YTD as tracked by most popular ETFs...
ETFs Outperformed Managed Biotechnology Funds YTD-FBT Is the Leader
2014 YTD- ETFs Outperformed Managed Funds In Biotech In the past managed life science funds outperformed ETFs but this has reversed in 2014. Fidelity's flagship Select Biotechnology Portfolio...
Rayno Diagnostics and Tools Stocks: GHDX, ILMN, QGEN, RGDX.
Rayno Life Science Stocks Focused on Genetic Tests and Biomarkers We have been writing about molecular diagnostics and tools stocks for over 5 years. Here is the summary of our Portfolio. Yesterday...
BIO 2014 Update #1 Personalized Medicine-Megatrend Momentum Continues
Challenges Ahead But Sequencing Is A Driver We first reported on Personalized Medicine in 2010 with an article on the importance of Biomarkers for exploiting breakthroughs in the molecular basis...
Vertex (VRTX) Soars 42% On Cystic Fibrosis Breakthrough Update-1
Data To Be Submitted in Q4 For Approval Two Phase III studies with combination drug showed clinically significant improvements in lung function Rayno Life Science Pick and Deja Vu Trade Last April...
BIO International Convention San Diego, CA This Week
Biotech Stocks Weak After 30 Day Rally NASDAQ at 4365 We will be attending the 2014 BIO International Convention this week. We do not expect any major scientific developments but will try to keep...